Sanofi and GSK seek approval for Covid-19 vaccine
The drugmakers hope to catch up with rivals after reporting positive results from late-stage clinical trials
Stay updated with breaking news from Thomas Triomphe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The drugmakers hope to catch up with rivals after reporting positive results from late-stage clinical trials
WBAL Radio 1090 AM - Sanofi and GSK plan to ask regulators to authorize their COVID-19 vaccine
Thiago Prudencio/SOPA Images/LightRocket via Getty Images(WASHINGTON) -- Drugmakers Sanofi and GlaxoSmithKline announced Wednesday they are planning to ask regulators to authorize their new COVID-19 vaccine candidate. The companies said data shows the shot works either as a primary vaccine, with 100% effectiveness against severe disease and hospitalization, or as a booster shot to raise antibody levels. Although they are submitting a request for authorization more than a year after Pfizer-BioNTech, Moderna and Johnson & Johnson were approved in the U.S., Sanofi and GSK are hoping to differ...
The WHO says the more transmissible BA.2 Omicron subvariant is now dominant in 18 nations.